| name | Aspirin |
| classification | Nonsteroidal Anti-inflammatory Drug (NSAID) |
| pharmacokinetics | Aspirin is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are achieved within 30 minutes to 2 hours. It is primarily metabolized in the liver and excreted in the urine. |
| suggested dosage | | adult pain fever | 325-650 mg every 4-6 hours, as needed. |
|
| indications | | 1 | Relief of mild to moderate pain (headache, muscle aches) | | 2 | Reduction of fever | | 3 | Reduction of risk of heart attack and stroke (in some cases) |
|
| safety in pregnancy | Aspirin use in pregnancy is generally not recommended, particularly in the later stages. Consult a doctor before taking any medication during pregnancy. |
| safety in breastfeeding | Aspirin can pass into breast milk. Consult a doctor to determine if it is safe for breastfeeding mothers. |
| side effects | | 1 | Gastrointestinal upset (nausea, heartburn, stomach pain) | | 2 | Bleeding risk (increased risk of bruising or bleeding) | | 3 | Allergic reactions (rash, hives, difficulty breathing) | | 4 | Reye's syndrome (rare but serious risk in children with viral infections) |
|
| alternatives | |
| contraindications | | 1 | History of aspirin allergy | | 2 | Peptic ulcer disease | | 3 | Bleeding disorders | | 4 | Certain kidney or liver conditions |
|
| interactions | | 1 | Certain medications like anticoagulants (blood thinners) and other NSAIDs | | 2 | Alcohol (can increase stomach irritation) |
|
| warnings and precautions | | 1 | Use with caution in patients with kidney or liver problems. | | 2 | Monitor for signs of bleeding. | | 3 | Do not use in children or adolescents with viral infections unless directed by a doctor. |
|
| additional information | Dosage and use should be determined by a medical professional. This information is for educational purposes only and should not be considered medical advice. |
| dosage notes | Consult a doctor for specific dosing recommendations and appropriate dosage for children and adolescents. |
